<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03401632</url>
  </required_header>
  <id_info>
    <org_study_id>HSeveroOchoa</org_study_id>
    <nct_id>NCT03401632</nct_id>
  </id_info>
  <brief_title>Enteral Nutrition and Vasoactive Drugs</brief_title>
  <acronym>NUTRIVAD</acronym>
  <official_title>Enteral Nutrition in Critically Ill Patients Undergoing Vasoactive Drugs Therapy. The NUTRIVAD Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Severo Ochoa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario 12 de Octubre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Severo Ochoa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Enteral nutrition in critically ill patients undergoing vasoactive support due to hemodynamic
      instability is controversial. Hypothesis: enteral nutrition delivered in such patients can be
      feasible and safe.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nutrition support in critically ill patients undergoing vasoactive support due to hemodynamic
      instability is controversial and challenging. However, if it is delivered according to an
      enteral nutrition protocol and under proper medical supervision, it can be feasible and safe.
      The present multicenter prospective study was designed to examine the feasibility and safety
      of enteral nutrition support in such patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dose of vasoactive drugs.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>Dose of vasoactive drugs (highest daily), in μg/kg/min.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Kilocalories delivered by enteral route and Energy balance (Kilocalories delivered by enteral nutrition — (minus) enteral nutrition target in Kilocalories).</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>Main Enteral nutrition efficacy-related variables. Enteral nutrition target was 25 Kilocalories/Kg, if body mass index (BMI) was between 20 and 30. Corrections were made if BMI was under 20/ or over 30.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Enteral nutrition-related mesenteric ischemia.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>Main enteral nutrition- safety related variable, suspected by the presence of warning signs (clinical, analytical, radiological), confirmed by laparotomy/laparoscopy, arteriography or angio-CT.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood lactate.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>Daily peak blood lactate, in mmol/l.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac index.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>Daily lowest cardiac index, in L/min/m^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical circulatory support.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>Dependence on Mechanical circulatory support (intra-aortic balloon pump, mechanical circulatory assistance, or extracorporeal membrane oxygenation).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from Intensive Care Unit admission to the start of enteral nutrition.</measure>
    <time_frame>Up to 120 hours after Intensive Care Unit Admission.</time_frame>
    <description>Time frame in hours from Intensive Care Unit admission to the start of enteral nutrition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutrition Tolerance.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>Kilocalories delivered by enteral nutrition, divided by nutrition target in Kilocalories, expressed as percentage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High gastric residual volume.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission</time_frame>
    <description>Gastric residual volume was described as high when &gt;500 mL was obtained in each assessment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abdominal distention.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>A change in the abdomen detected in a physical examination, with an increase in abdominal cavity size relative to that recorded in the pre-enteral nutrition examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regurgitation.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>Presence of Enteral nutrition feed in the oral cavity or oropharynx, as well as its spontaneous drainage by the oral and/or nasal route</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Enteral nutrition-related diarrhea.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>5 or more liquid stools in 24 hours or more than two 1000-mL stool volumes, each deposited over a 24-hour period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Constipation.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>Lack of bowel movements in 7 days from the onset of enteral nutrition or for 3 days in the first week of admission.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bronchoaspiration.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>The presence of respiratory secretions of similar characteristics to the prescribed enteral nutrition feed, confirmed by the glucose-oxidase technique in tracheal secretion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasogastric tube complications.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>Obstruction or misplacement/accidental extubation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Enteral nutrition interruptions.</measure>
    <time_frame>Daily to a maximum of 14 days after Intensive Care Unit Admission.</time_frame>
    <description>Need to interrupt or discontinue enteral nutrition (and reasons)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Enteral Nutrition</condition>
  <condition>Vasopressor Agents</condition>
  <condition>Hemodynamics Instability</condition>
  <condition>Critical Care</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Enteral nutrition</intervention_name>
    <description>Enteral nutrition support</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Critically ill adults.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Authorization to participate in the study by informed consent.

          -  Dependence of vasoactive drugs and/or mechanical circulatory support to at least 48
             hours from Intensive Care Unit admission.

          -  Invasive mechanical ventilation time of at least 48 hours.

          -  Expected survival greater than 72 hours.

          -  ICU Stay greater than or equal to 72 hours.

        Exclusion Criteria:

          -  Refusal to participate in the study.

          -  Refractory shock, defined as the progressive elevation of the dose of vasoactive drugs
             and / or markers of tissue hypoperfusion, or mean arterial pressure ≤ 60 mm Hg despite
             the therapeutic maneuvers.

          -  History of significant abdominal vascular disease (ischemic colitis, chronic
             mesenteric ischemia, aortic aneurysm abdominal, aortic dissection with involvement of
             mesenteric vessels, etc).

          -  Absolute contraindication for the onset of enteral nutrition (active gastrointestinal
             hemorrhage, intestinal obstruction, etc.) or patients with a non-functional
             gastrointestinal tract.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose Luis Flordelís Lasierra, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitario Severo Ochoa. Leganés. Madrid. Spain.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan Carlos Montejo González, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario 12 de Octubre. Madrid. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luis Juan Terceros Almanza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario 12 de Octubre. Madrid. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Luis Blesa Malpica, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Clínico San Carlos. Madrid. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emilio Renes Carreño, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario 12 de Octubre. Madrid. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>María Lourdes Cordero Lorenzana, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complejo Hospitalario Universitario A Coruña. Galicia. Spain.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan Carlos López Delgado, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario de Bellvitge. Cataluña. Spain.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paola Zárate Chug, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Miguel Servet. Zaragoza. Spain.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Belén Vila García, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Infanta Cristina. Parla. Madrid. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rosa María Gastaldo Simeón, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Manacor. Mallorca. Islas Baleares. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fátima Martínez Lozano Aranaga, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General Universitario Reina Sofía. Murcia. Spain.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carolina Lorencio Cárdenas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario de Girona Josep Trueta. Gerona. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mónica Zamora Elson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Barbastro. Huesca. Aragón. Spain.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Clara Vaquerizo Alonso, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario de Fuenlabrada. Madrid. Spain.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>María Luisa Bordejé Laguna, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Germans Trias i Pujol. Badalona. Barcelona. Cataluña. Spain.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Esther Portugal Rodríguez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Lucus Augusti. Lugo. Galicia. Spain.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lluís Servià Goixart, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Arnau de Villanova. Lérida. Cataluña. Spain.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ana Martín Luengo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Río Ortega. Valladolid. Castilla y León. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carmen Martín Parra, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario del Tajo. Aranjuez. Madrid. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lidón Mateu Campos, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General Universitario de Castellón. Comunidad Valenciana. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan Francisco Fernández Ortega, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Regional Universitario de Málaga. Andalucía. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Miguel Ángel García Martínez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario de Torrevieja. Comunidad Valenciana. Spain.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos Serón Arbeloa, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de San Jorge. Huesca. Aragón. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elisabeth Navas Moya, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Mútua Terrassa. Barcelona. Spain.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>María del Mar Juan Díaz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínico Universitario de Valencia. Comunidad Valenciana. Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander Agrifolio Rotaeche, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario La Paz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pilar Martínez García, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Puerto Real. Cádiz. Andalucía. Spain.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose Luis Flordelís Lasierra, MD, PhD</last_name>
    <phone>34 914818000</phone>
    <phone_ext>5070</phone_ext>
    <email>makalyconru@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Juan Carlos Montejo González, MD, PhD</last_name>
    <phone>Tno: 91 3908907</phone>
    <email>juancarlos.montejo@salud.madrid.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitario Puerto Real</name>
      <address>
        <city>Cadiz</city>
        <state>Andalucía</state>
        <zip>11510</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pilar Martínez García, MD</last_name>
      <email>pilar.martinezgarcia@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Pilar Martínez García, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Regional Universitario de Málaga</name>
      <address>
        <city>Málaga</city>
        <state>Andalucía</state>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Francisco Fernández Ortega, MD</last_name>
      <email>jfezortega@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Juan Francisco Fernández Ortega, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Francisco Martínez Carmona, Med Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de San Jorge</name>
      <address>
        <city>Huesca</city>
        <state>Aragón</state>
        <zip>22004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Serón Arbeloa, MD, PhD</last_name>
      <email>cseronar@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Carlos Serón Arbeloa, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paula Omedas Bonafonte, Med Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Barbastro</name>
      <address>
        <city>Huesca</city>
        <state>Aragón</state>
        <zip>22300</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mónica Zamora Elson, MD</last_name>
      <email>monica_z_elson@hotmail.es</email>
    </contact>
    <investigator>
      <last_name>Mónica Zamora Elson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <state>Aragón</state>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paola Zárate Chug, MD</last_name>
      <email>paolazarate_248@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>María Fuster Cabré</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pablo Ruiz de Gopegui</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fernando Fuentes Gorgas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Monge Sola</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Inés Martínez Arroyo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arancha Utante Vázquez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paola Zárate Chug, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Río Hortega</name>
      <address>
        <city>Valladolid</city>
        <state>Castilla Y León</state>
        <zip>47012</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Martín Luengo, MD</last_name>
      <email>anauvi@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>Ana Martín Luengo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Bellvitge</name>
      <address>
        <city>Barcelona</city>
        <state>Cataluña</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Carlos López Delgado, MD, PhD</last_name>
      <email>juancarloslopezde@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Juan Carlos López Delgado, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aleix López Oganissian, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Cruz Bardina, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ainhoa García-Marrón Gallego, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sònia Aguirre Álvarez, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mireia Sánchez Escudero, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marta Martínez Orellana, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sara González del Hoyo, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nerea Latorre Feliu, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Meritxell Martínez Medán, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Sanz Mellado, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alejandro López López, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gloria Muñoz del Río, Med Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Germans Trias i Pujol</name>
      <address>
        <city>Barcelona</city>
        <state>Cataluña</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María Luisa Bordejé Laguna, MD</last_name>
      <email>luisabordeje@gmail.com</email>
    </contact>
    <investigator>
      <last_name>María Luisa Bordejé Laguna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Triginer Roig, Med Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Girona Josep Trueta</name>
      <address>
        <city>Gerona</city>
        <state>Cataluña</state>
        <zip>17007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolina Lorencio Cárdenas, MD</last_name>
      <email>carol_lorencio@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Carolina Lorencio Cárdenas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claudia Vera, Med Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Arnau de Villanova</name>
      <address>
        <city>Lérida</city>
        <state>Cataluña</state>
        <zip>25198</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lluís Servià Goixart, MD, PhD</last_name>
      <email>lserviag@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Lluís Servià Goixart, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nuria Ramón Coll, Med Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gabriel Jiménez Jiménez, Med Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Mútua Terrassa</name>
      <address>
        <city>Terrassa</city>
        <state>Cataluña</state>
        <zip>08221</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabeth Navas Moya, MD</last_name>
      <email>enavas@mutuaterrassa.es</email>
    </contact>
    <investigator>
      <last_name>Elisabeth Navas Moya, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Castellón</name>
      <address>
        <city>Castelló de la Plana</city>
        <state>Comunidad Valenciana</state>
        <zip>12004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María Lidón Mateu Campos, MD, PhD</last_name>
      <email>mateuli@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>María Lidón Mateu Campos, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Torrevieja</name>
      <address>
        <city>Torrevieja</city>
        <state>Comunidad Valenciana</state>
        <zip>03186</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Ángel García Martínez, MD</last_name>
      <email>garciamartinez.ma@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Miguel Ángel García Martínez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <state>Comunidad Valenciana</state>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María del Mar Juan Díaz, MD</last_name>
      <email>mar604@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>María del Mar Juan Díaz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ángela Jordá Miñana, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario A Coruña</name>
      <address>
        <city>A Coruña</city>
        <state>Galicia</state>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María Lourdes Cordero Lorenzana, MD</last_name>
      <email>MA.Lourdes.Cordero.Lorenzana@sergas.es</email>
    </contact>
    <investigator>
      <last_name>María Lourdes Cordero Lorenzana, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Lucus Augusti</name>
      <address>
        <city>Lugo</city>
        <state>Galicia</state>
        <zip>27003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital de Manacor.</name>
      <address>
        <city>Palma De Mallorca</city>
        <state>Islas Baleares</state>
        <zip>07500</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosa María Gastaldo Simeón, MD</last_name>
      <email>rgastaldo@hmanacor.org</email>
    </contact>
    <investigator>
      <last_name>Rosa María Gastaldo Simeón, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario del Tajo</name>
      <address>
        <city>Aranjuez</city>
        <state>Madrid</state>
        <zip>28300</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmen Martín Parra, MD</last_name>
      <email>mcmparra@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Carmen Martín Parra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Fuenlabrada</name>
      <address>
        <city>Fuenlabrada</city>
        <state>Madrid</state>
        <zip>28942</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clara Vaquerizo Alonso, MD</last_name>
      <email>clara.vaquerizo@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Clara Vaquerizo Alonso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raquel Del Olmo Monge, Med Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Severo Ochoa</name>
      <address>
        <city>Leganés.</city>
        <state>Madrid</state>
        <zip>28911</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Ramón Mampaso Recio, MD</last_name>
      <phone>91 481 80 00</phone>
      <phone_ext>5070</phone_ext>
      <email>ramon.mampaso@salud.madrid.org</email>
    </contact>
    <contact_backup>
      <last_name>José Luis Flordelís Lasierra, MD, PhD</last_name>
      <phone>91 481 80 00</phone>
      <phone_ext>5070</phone_ext>
      <email>makalyconru@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Victoria Adriana Benítez Ferreiro, Med Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>José Ramón Mampaso Recio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>José Antonio José Antonio González Calle, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eva María Espinosa Serrano, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Irene Jiménez del Río, Med Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Infanta Cristina</name>
      <address>
        <city>Parla</city>
        <state>Madrid</state>
        <zip>28981</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belén Vila García, MD</last_name>
      <email>belenvilag@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>Belén Vila García, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Luis Blesa Malpica, MD, PhD</last_name>
      <email>ablesamal@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Silmary Maichle, Med Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonio Luis Blesa Malpica, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Carlos Montejo González, MD, PhD</last_name>
      <phone>91 3908907</phone>
      <email>juancarlos.montejo@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>María Victoria Transmonte Martínez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luis Juan Terceros Almanza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emilio Renes Carreño, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Agrifolio Rotaeche, MD</last_name>
      <email>aar_11@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Alexander Agrifolio Rotaeche</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Reina Sofía</name>
      <address>
        <city>Murcia</city>
        <zip>30003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fátima Martínez Lozano Aranaga, MD</last_name>
      <email>fatiaranaga@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Fátima Martínez Lozano Aranaga, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Noemí Llamas Fernández</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juana María Serrano Navarro, Med Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2018</study_first_submitted>
  <study_first_submitted_qc>January 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2018</study_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Severo Ochoa</investigator_affiliation>
    <investigator_full_name>Jose Luis Flordelis Lasierra, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Enteral nutrition</keyword>
  <keyword>Vasoactive Drugs</keyword>
  <keyword>Critical Care</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The study protocol and Informed Consent Form would be shared with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

